Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis

by Darrell H. S. Tan, Rupesh Agrawal, Ruanne V. Barnabas, Jon T. Giles, Peter Dull
Published 2020-09-01

Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.

by Jon T Giles, Erika Darrah, Sonye Danoff, Cheilonda Johnson, Felipe Andrade, Antony Rosen, Joan M Bathon
Published 2014-01-01

Increased generation of TRAP expressing multinucleated giant cells in patients with granulomatosis with polyangiitis.

by Jin Kyun Park, Frederic Askin, Jon T Giles, Marc K Halushka, Antony Rosen, Stuart M Levine
Published 2012-01-01

Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis.

by Cheilonda Johnson, Jon T Giles, Joan Bathon, David Lederer, Eric A Hoffman, R Graham Barr, Sonye K Danoff
Published 2016-01-01

Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis

by Daniela Graham, Christopher Ritchlin, Jon T Giles, Juan J Gomez Reino, Philip Helliwell, Pamela Young, Wael Joseph, Rajiv Mundayat
Published 2021-04-01

Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies

by Christopher T. Ritchlin, Jon T. Giles, Alexis Ogdie, Juan J. Gomez‐Reino, Philip Helliwell, Pamela Young, Cunshan Wang, Joseph Wu, Ana Belén Romero, John Woolcott, Lori Stockert
Published 2020-10-01

Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis

by Erika Darrah, Jon T. Giles, Ryan L. Davis, Pooja Naik, Hong Wang, Maximilian F. Konig, Laura C. Cappelli, Clifton O. Bingham, Sonye K. Danoff, Felipe Andrade
Published 2018-11-01

Plasma adiponectin levels are associated with circulating inflammatory cytokines in autoantibody positive first-degree relatives of rheumatoid arthritis patients.

by Jan M Hughes-Austin, Kevin D Deane, Jon T Giles, Lezlie A Derber, Gary O Zerbe, Dana M Dabelea, Jeremy Sokolove, William H Robinson, V Michael Holers, Jill M Norris
Published 2018-01-01

Testing the Effects of Disease‐Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial

by Jon T. Giles, Pamela M. Rist, Katherine P. Liao, Ahmed Tawakol, Zahi A. Fayad, Venkatesh Mani, Nina P. Paynter, Paul M. Ridker, Robert J. Glynn, Fengxin Lu, Rachel Broderick, Meredith Murray, Kathleen M. M. Vanni, Daniel H. Solomon, Joan M. Bathon
Published 2021-06-01